137310 — SD Biosensor Income Statement
0.000.00%
- KR₩1tn
- KR₩1tn
- KR₩695bn
- 72
- 46
- 57
- 64
Annual income statement for SD Biosensor, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,686,163 | 2,929,961 | 2,932,001 | 655,677 | 694,574 |
Cost of Revenue | |||||
Gross Profit | 858,162 | 1,593,923 | 1,392,995 | 126,002 | 339,386 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 947,899 | 1,544,511 | 1,794,011 | 1,003,630 | 883,027 |
Operating Profit | 738,264 | 1,385,450 | 1,137,990 | -347,953 | -188,453 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 717,237 | 1,464,509 | 1,242,088 | -438,614 | -219,181 |
Provision for Income Taxes | |||||
Net Income After Taxes | 621,614 | 1,088,124 | 908,789 | -467,904 | -98,140 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 615,636 | 1,088,471 | 911,362 | -467,712 | -98,411 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 615,636 | 1,088,471 | 911,362 | -467,712 | -98,411 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5,966 | 11,189 | 9,072 | -3,627 | -112 |
Dividends per Share |